Hemibodies vernichten Krebszellen - Kampf gegen Krebs e.V.
Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge. - ppt download
Loop | Hannes Neuweiler
Cancer Immune Therapy: Current and Future Strategies - Google Books
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features - Biology of Blood and Marrow Transplantation
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramed
Gernot Stuhler | Management-Krankenhaus
12) Patent Application Publication (10) Pub. No.: US 2015/0079093 A1
ABOUT US - 99designs-5d6bbd5555df1s Webseite!
Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability – Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML -
Glossary - Cancer Immune Therapy - Wiley Online Library
Innovativ und erfolgreich beim "Preis der BioRegionen" - einBLICK - Online-Magazin der Universität Würzburg
A helping hand from Hemibody | Drug Discovery News
Hemibodies – a new antibody format for cancer immunotherapy - BMBF GO-Bio
Der Initiator Prof. Dr. Gernot Stuhler ist zurück am Universitätsklinikum
Variant signaling topology at the cancer cell–T-cell interface induced by a two-component T-cell engager | Cellular & Molecular Immunology
Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal: Cell
Weniger Nebenwirkungen, bessere Wirksamkeit - einBLICK - Online-Magazin der Universität Würzburg
Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed after Autograft: A Multicenter Retrospective Study Based on Do
PDF) Erratum: Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo | William Sessa - Academia.edu
On-target restoration of a split T cell-engaging antibody for precision immunotherapy. - Abstract - Europe PMC
